BioFluidica, Inc. will be showcased their Fetal Cell-Based DNA Test (in development) at #SMFM2024 from Feb 11-14th!
Visitors came to Booth #519 to learn more about their cutting-edge, liquid biopsy rare cell/EV isolation platform’s capabilities and their vision for the future of prenatal (and oncology) testing.
